TOBRAMYCIN SULFATE

TOBRAMYCIN SULFATE was reported 12547 times

TOBRAMYCIN SULFATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CRONOBACTER INFECTION 7 0.4667
1 INFECTIVE CORNEAL ULCER 8 0.2857
2 FLAVOBACTERIUM INFECTION 8 0.1818
3 CHOROIDITIS 64 0.1711
4 HEPATOSPLENOMEGALY NEONATAL 7 0.1667
5 INFECTIVE KERATITIS 11 0.1549
6 ACQUIRED FACTOR V DEFICIENCY 14 0.1273
7 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 624 0.1145
8 ADMINISTRATION SITE SCAR 7 0.1129
9 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 91 0.1019
10 CYSTIC FIBROSIS LUNG 12 0.0938
11 VENTILATION PERFUSION MISMATCH 23 0.0819
12 KERATITIS FUNGAL 17 0.0817
13 CYSTIC FIBROSIS 430 0.0776
14 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 30 0.0739
15 CYSTIC FIBROSIS RELATED DIABETES 10 0.0685
16 KERATITIS BACTERIAL 11 0.0675
17 TRACHEOSTOMY INFECTION 8 0.0656
18 NECROTISING SCLERITIS 9 0.0621
19 SLE ARTHRITIS 16 0.0563
20 INFECTIVE EXACERBATION OF BRONCHIECTASIS 16 0.0521
21 CORNEAL INFILTRATES 16 0.0510
22 CORNEAL THINNING 12 0.0467
23 ELBOW DEFORMITY 16 0.0462
24 OTOTOXICITY 83 0.0448
25 VITAMIN K DEFICIENCY 18 0.0448
26 CORNEAL NEOVASCULARISATION 11 0.0445
27 CORNEAL PERFORATION 28 0.0444
28 BLOOD IMMUNOGLOBULIN E DECREASED 7 0.0435
29 MYCOBACTERIUM CHELONAE INFECTION 32 0.0433
30 CORNEAL EPITHELIUM DEFECT 22 0.0379
31 FACTOR V INHIBITION 7 0.0361
32 CHOLANGITIS INFECTIVE 9 0.0338
33 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
34 TRICHOSPORON INFECTION 13 0.0321
35 TRACHEITIS 24 0.0315
36 BURKHOLDERIA CEPACIA COMPLEX INFECTION 9 0.0315
37 HYPOTONY OF EYE 13 0.0310
38 PSEUDOMONAS INFECTION 256 0.0298
39 INCREASED VISCOSITY OF BRONCHIAL SECRETION 19 0.0298
40 PULMONARY FUNCTION TEST DECREASED 130 0.0297
41 HYPOPYON 24 0.0290
42 LUNG INFECTION PSEUDOMONAL 16 0.0287
43 RESPIRATORY TRACT INFECTION BACTERIAL 14 0.0281
44 PNEUMONIA PSEUDOMONAL 42 0.0274
45 RETINOPATHY OF PREMATURITY 15 0.0271
46 DISTAL INTESTINAL OBSTRUCTION SYNDROME 9 0.0267
47 INFECTED DERMAL CYST 9 0.0249
48 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 13 0.0248
49 RESPIRATORY TRACT IRRITATION 24 0.0230
50 OVERLAP SYNDROME 16 0.0229
51 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 20 0.0216
52 MYCOBACTERIUM ABSCESSUS INFECTION 15 0.0210
53 TRACHEAL HAEMORRHAGE 7 0.0199
54 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 49 0.0198
55 CORNEAL OPACITY 26 0.0190
56 APLASTIC ANAEMIA 96 0.0184
57 PSEUDOMONAS TEST POSITIVE 15 0.0183
58 PSOAS ABSCESS 11 0.0177
59 HYPERBILIRUBINAEMIA NEONATAL 10 0.0172
60 THROMBOCYTOPENIA NEONATAL 7 0.0166
61 LUNG TRANSPLANT 58 0.0164
62 CORNEAL SCAR 8 0.0159
63 BRONCHIAL WALL THICKENING 11 0.0153
64 SPUTUM INCREASED 33 0.0152
65 BACTERIAL DISEASE CARRIER 11 0.0151
66 RENAL TUBULAR INJURY 18 0.0148
67 ENDOPHTHALMITIS 87 0.0145
68 RENAL TUBULAR NECROSIS 141 0.0144
69 ULCERATIVE KERATITIS 39 0.0142
70 LINEAR IGA DISEASE 23 0.0138
71 LUNG TRANSPLANT REJECTION 9 0.0136
72 CONJUNCTIVAL OEDEMA 14 0.0136
73 FORCED EXPIRATORY VOLUME DECREASED 38 0.0134
74 VESTIBULAR DISORDER 16 0.0131
75 CORNEAL EROSION 7 0.0130
76 SJS-TEN OVERLAP 9 0.0128
77 BRONCHIECTASIS 86 0.0128
78 CONJUNCTIVAL HYPERAEMIA 45 0.0126
79 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13 0.0122
80 SERRATIA INFECTION 9 0.0121
81 SPUTUM ABNORMAL 8 0.0121
82 BRONCHITIS BACTERIAL 9 0.0119
83 DEAFNESS NEUROSENSORY 38 0.0115
84 NEPHROGENIC ANAEMIA 53 0.0114
85 FUSARIUM INFECTION 8 0.0114
86 SCEDOSPORIUM INFECTION 8 0.0113
87 DEVICE RELATED THROMBOSIS 11 0.0112
88 SPUTUM CULTURE POSITIVE 9 0.0111
89 BRONCHIAL SECRETION RETENTION 14 0.0110
90 ABDOMINAL COMPARTMENT SYNDROME 7 0.0110
91 ACINETOBACTER INFECTION 12 0.0110
92 RHONCHI 15 0.0109
93 HYPERPARATHYROIDISM SECONDARY 27 0.0108
94 CORNEAL OEDEMA 24 0.0107
95 REBOUND ACID HYPERSECRETION 32 0.0106
96 PAINFUL RESPIRATION 25 0.0104
97 STENOTROPHOMONAS INFECTION 14 0.0103
98 CHEST INJURY 21 0.0101
99 PATHOGEN RESISTANCE 91 0.0100
100 HEART TRANSPLANT 9 0.0099
101 OCULAR HYPERTENSION 19 0.0098
102 INCREASED BRONCHIAL SECRETION 25 0.0098
103 JAW FRACTURE 21 0.0097
104 NEPHROPATHY TOXIC 103 0.0092
105 KERATITIS 26 0.0085
106 NASAL INFLAMMATION 9 0.0085
107 SINUS OPERATION 20 0.0084
108 PERIORBITAL PAIN 7 0.0083
109 CONTINUOUS HAEMODIAFILTRATION 8 0.0082
110 RED MAN SYNDROME 7 0.0080
111 RASH MORBILLIFORM 22 0.0079
112 TOXIC ANTERIOR SEGMENT SYNDROME 8 0.0073
113 INTRAOCULAR PRESSURE INCREASED 92 0.0072
114 PNEUMONIA STAPHYLOCOCCAL 14 0.0071
115 PULMONARY FUNCTION TEST ABNORMAL 11 0.0071
116 BLOOD CULTURE POSITIVE 21 0.0070
117 DRUG RESISTANCE 180 0.0070
118 PLATELET TRANSFUSION 9 0.0070
119 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 16 0.0069
120 CORNEAL DISORDER 15 0.0068
121 SPUTUM DISCOLOURED 63 0.0066
122 RUBBER SENSITIVITY 10 0.0065
123 TOXIC EPIDERMAL NECROLYSIS 99 0.0065
124 RHINOVIRUS INFECTION 25 0.0064
125 EYELID PAIN 13 0.0064
126 TRACHEOSTOMY 9 0.0063
127 LIP HAEMORRHAGE 8 0.0063
128 ANGLE CLOSURE GLAUCOMA 16 0.0063
129 PSEUDOMEMBRANOUS COLITIS 14 0.0063
130 LUNG ABSCESS 13 0.0062
131 RESPIRATORY DISORDER NEONATAL 10 0.0062
132 DRUG LEVEL INCREASED 102 0.0062
133 CONJUNCTIVITIS ALLERGIC 9 0.0061
134 METAMORPHOPSIA 11 0.0060
135 PULMONARY HAEMORRHAGE 46 0.0059
136 CHRONIC RESPIRATORY FAILURE 7 0.0058
137 HAEMOPTYSIS 160 0.0057
138 ERYTHEMA OF EYELID 31 0.0057
139 INFUSION SITE DISCHARGE 10 0.0057
140 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 44 0.0057
141 RESPIRATORY SYMPTOM 16 0.0056
142 RESPIRATORY TRACT INFECTION VIRAL 13 0.0056
143 END STAGE RENAL DISEASE 100 0.0055
144 OBLITERATIVE BRONCHIOLITIS 7 0.0053
145 VASCULITIS 61 0.0052
146 ASPERGILLUS INFECTION 34 0.0052
147 PSEUDOMONAL SEPSIS 9 0.0051
148 INFUSION SITE BRUISING 11 0.0051
149 WALKING AID USER 32 0.0048
150 MYCOBACTERIUM AVIUM COMPLEX INFECTION 13 0.0048
151 SYSTEMIC CANDIDA 12 0.0048
152 CEREBELLAR INFARCTION 8 0.0047
153 UVEITIS 64 0.0047
154 ORAL CANDIDIASIS 62 0.0047
155 DEAFNESS BILATERAL 8 0.0047
156 LUNG INFECTION 73 0.0047
157 STAPHYLOCOCCAL SEPSIS 23 0.0047
158 EXOPHTHALMOS 10 0.0046
159 CENTRAL VENOUS CATHETERISATION 14 0.0046
160 FUNGAL PERITONITIS 7 0.0046
161 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
162 ACUTE KIDNEY INJURY 690 0.0045
163 BRONCHIAL DISORDER 7 0.0045
164 STREPTOCOCCAL INFECTION 25 0.0045
165 TOTAL LUNG CAPACITY DECREASED 7 0.0044
166 PNEUMONIA BACTERIAL 40 0.0044
167 SOCIAL PROBLEM 18 0.0043
168 PUPILLARY REFLEX IMPAIRED 8 0.0043
169 HEPATOSPLENOMEGALY 11 0.0043
170 EYE PAIN 241 0.0043
171 MECHANICAL VENTILATION 8 0.0042
172 MULTIPLE-DRUG RESISTANCE 13 0.0042
173 RESPIRATORY SYNCYTIAL VIRUS INFECTION 36 0.0041
174 STEATORRHOEA 11 0.0041
175 CLOSTRIDIUM TEST POSITIVE 9 0.0041
176 EYE OEDEMA 10 0.0041
177 GASTROINTESTINAL TUBE INSERTION 10 0.0040
178 PRODUCTIVE COUGH 191 0.0040
179 GASTROINTESTINAL HYPOMOTILITY 9 0.0040
180 INFUSION SITE HAEMORRHAGE 13 0.0039
181 HAEMODIALYSIS 33 0.0039
182 EYELID DISORDER 9 0.0039
183 PNEUMOMEDIASTINUM 7 0.0039
184 CHRONIC KIDNEY DISEASE 293 0.0039
185 BRONCHOSPASM 55 0.0039
186 PNEUMOTHORAX 61 0.0038
187 AORTIC ANEURYSM 29 0.0038
188 PNEUMONIA KLEBSIELLA 7 0.0038
189 ADENOVIRUS INFECTION 11 0.0038
190 RALES 22 0.0038
191 VITRITIS 7 0.0038
192 LUNG DISORDER 184 0.0038
193 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 63 0.0037
194 CREPITATIONS 11 0.0037
195 TUBULOINTERSTITIAL NEPHRITIS 68 0.0036
196 EYE INFECTION 40 0.0035
197 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
198 PROTEINURIA 67 0.0035
199 APHONIA 49 0.0035
200 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
201 BACTERIAL INFECTION 65 0.0035
202 PERIORBITAL OEDEMA 18 0.0035
203 HYPERTRANSAMINASAEMIA 24 0.0034
204 VISUAL ACUITY REDUCED 114 0.0034
205 ARTHRITIS BACTERIAL 14 0.0034
206 BACTERIAL SEPSIS 11 0.0034
207 SWELLING OF EYELID 21 0.0033
208 WEIGHT ABNORMAL 8 0.0033
209 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
210 ATELECTASIS 32 0.0033
211 EMERGENCY CARE 10 0.0033
212 PNEUMONIA FUNGAL 13 0.0033
213 FOREIGN BODY SENSATION IN EYES 21 0.0033
214 PATENT DUCTUS ARTERIOSUS 13 0.0033
215 EYELID OEDEMA 38 0.0033
216 PHOTOPHOBIA 61 0.0032
217 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
218 DIASTOLIC DYSFUNCTION 10 0.0032
219 CONJUNCTIVITIS 60 0.0032
220 STAPHYLOCOCCAL BACTERAEMIA 14 0.0032
221 INFECTION 465 0.0032
222 GRAFT VERSUS HOST DISEASE 23 0.0032
223 EYELID IRRITATION 8 0.0032
224 RENAL FAILURE ACUTE 134 0.0032
225 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
226 STAPHYLOCOCCAL INFECTION 103 0.0031
227 OCULAR DISCOMFORT 35 0.0031
228 ENTEROCOCCAL INFECTION 15 0.0031
229 OXYGEN SATURATION DECREASED 174 0.0031
230 MULTIPLE ORGAN DYSFUNCTION SYNDROME 86 0.0030
231 SEPTIC SHOCK 131 0.0030
232 HOSPITALISATION 462 0.0030
233 HYPERCAPNIA 9 0.0030
234 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 15 0.0030
235 CHRONIC SINUSITIS 11 0.0029
236 OXYGEN CONSUMPTION INCREASED 7 0.0029
237 PORTAL HYPERTENSION 9 0.0029
238 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 75 0.0029
239 VITREOUS HAEMORRHAGE 8 0.0029
240 LYMPHADENITIS 7 0.0029
241 PULMONARY CONGESTION 38 0.0029
242 INFUSION SITE SWELLING 18 0.0029
243 IRIDOCYCLITIS 9 0.0028
244 RESPIRATORY DISORDER 85 0.0028
245 DISEASE COMPLICATION 13 0.0028
246 LUNG INFILTRATION 25 0.0028
247 PERIORBITAL SWELLING 16 0.0028
248 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
249 SECRETION DISCHARGE 35 0.0028
250 ENTEROCOLITIS 16 0.0028
251 BRAIN ABSCESS 7 0.0028
252 HAEMOTHORAX 8 0.0028
253 HEPATOMEGALY 27 0.0027
254 GASTROINTESTINAL NECROSIS 8 0.0027
255 ABDOMINAL INFECTION 7 0.0027
256 MULTI-ORGAN FAILURE 47 0.0027
257 WHEEZING 161 0.0027
258 MUCORMYCOSIS 7 0.0027
259 RETINAL DISORDER 7 0.0027
260 INFUSION SITE REACTION 8 0.0027
261 PROTEIN TOTAL DECREASED 10 0.0027
262 RESPIRATION ABNORMAL 18 0.0026
263 STEVENS-JOHNSON SYNDROME 58 0.0026
264 FIBROSIS 8 0.0026
265 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
266 EYELIDS PRURITUS 8 0.0026
267 RESPIRATORY DISTRESS 70 0.0025
268 SERUM SICKNESS 7 0.0025
269 PNEUMONIA VIRAL 8 0.0025
270 OSTEOPENIA 38 0.0025
271 LUNG CONSOLIDATION 7 0.0025
272 RESPIRATORY TRACT INFECTION 65 0.0025
273 C-REACTIVE PROTEIN ABNORMAL 16 0.0025
274 RENAL FAILURE 331 0.0025
275 LACRIMATION INCREASED 74 0.0024
276 ACUTE RESPIRATORY FAILURE 47 0.0024
277 HYPOXIA 86 0.0024
278 NASAL POLYPS 12 0.0024
279 BREATH SOUNDS ABNORMAL 12 0.0024
280 CANDIDA INFECTION 41 0.0024
281 OBSTRUCTIVE AIRWAYS DISORDER 27 0.0024
282 INFLAMMATORY MARKER INCREASED 12 0.0024
283 PNEUMONIA 782 0.0024
284 ESCHERICHIA SEPSIS 7 0.0024
285 HYPERNATRAEMIA 12 0.0024
286 RETINAL DETACHMENT 22 0.0024
287 HEPATIC NECROSIS 9 0.0024
288 KLEBSIELLA INFECTION 12 0.0024
289 DEAFNESS 62 0.0024
290 PARANASAL SINUS HYPERSECRETION 9 0.0024
291 SMALL INTESTINAL OBSTRUCTION 29 0.0024
292 HAEMOLYTIC ANAEMIA 21 0.0023
293 PUSTULAR PSORIASIS 8 0.0023
294 RENAL INJURY 69 0.0023
295 OCULAR HYPERAEMIA 110 0.0023
296 MUCOSAL INFLAMMATION 60 0.0023
297 EOSINOPHILIA 40 0.0023
298 BACTERAEMIA 27 0.0023
299 DIALYSIS 32 0.0023
300 TRANSPLANT REJECTION 18 0.0022
301 BLEPHARITIS 9 0.0022
302 EYE PRURITUS 75 0.0022
303 HYPOVOLAEMIA 13 0.0022
304 HYPERBILIRUBINAEMIA 23 0.0022
305 ORGANISING PNEUMONIA 11 0.0022
306 INFUSION SITE PRURITUS 7 0.0022
307 VASCULAR DEVICE INFECTION 10 0.0022
308 RESPIRATORY FAILURE 160 0.0022
309 INTESTINAL ISCHAEMIA 12 0.0022
310 PROTHROMBIN TIME PROLONGED 13 0.0022
311 PATHOLOGICAL FRACTURE 11 0.0022
312 TINNITUS 99 0.0022
313 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
314 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 103 0.0021
315 UMBILICAL HERNIA 10 0.0021
316 PERIPHERAL VASCULAR DISORDER 11 0.0021
317 FEBRILE BONE MARROW APLASIA 9 0.0021
318 EYE DISCHARGE 22 0.0021
319 PULMONARY HYPERTENSION 44 0.0021
320 LEUKOCYTOSIS 38 0.0021
321 TRANSFUSION 22 0.0021
322 OLIGURIA 13 0.0021
323 INSURANCE ISSUE 32 0.0021
324 EXERCISE TOLERANCE DECREASED 12 0.0021
325 HORDEOLUM 9 0.0021
326 EJECTION FRACTION DECREASED 32 0.0021
327 COAGULOPATHY 34 0.0020
328 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
329 RESPIRATORY RATE INCREASED 18 0.0020
330 SINUS DISORDER 40 0.0020
331 LOW BIRTH WEIGHT BABY 16 0.0020
332 DERMATITIS EXFOLIATIVE 10 0.0020
333 ENCEPHALOPATHY 49 0.0020
334 CANDIDIASIS 8 0.0020
335 VIRAL INFECTION 66 0.0020
336 RASH MACULO-PAPULAR 44 0.0020
337 ANURIA 17 0.0020
338 IMMUNE THROMBOCYTOPENIA 9 0.0020
339 APPENDICECTOMY 7 0.0020
340 PERONEAL NERVE PALSY 11 0.0019
341 EYE SWELLING 72 0.0019
342 SEASONAL ALLERGY 27 0.0019
343 RENAL IMPAIRMENT 160 0.0019
344 BLOOD ALBUMIN DECREASED 15 0.0019
345 NYSTAGMUS 10 0.0019
346 MALNUTRITION 21 0.0019
347 LUNG NEOPLASM 8 0.0019
348 HEPATIC LESION 8 0.0018
349 DISSEMINATED INTRAVASCULAR COAGULATION 26 0.0018
350 HYDROCEPHALUS 10 0.0018
351 ACIDOSIS 14 0.0018
352 ANEURYSM 9 0.0018
353 MACULAR OEDEMA 10 0.0018
354 RESPIRATORY ACIDOSIS 7 0.0018
355 ASTHMA 200 0.0018
356 NEUROTOXICITY 31 0.0018
357 HYPOACUSIS 76 0.0018
358 ACUTE GRAFT VERSUS HOST DISEASE 8 0.0017
359 BLOOD PRESSURE SYSTOLIC INCREASED 34 0.0017
360 BLOOD UREA INCREASED 29 0.0017
361 EYE IRRITATION 99 0.0017
362 NEPHROPATHY 16 0.0017
363 CARDIOMEGALY 21 0.0017
364 HAEMODYNAMIC INSTABILITY 13 0.0017
365 ESCHERICHIA INFECTION 14 0.0017
366 BLOOD CREATININE INCREASED 111 0.0017
367 CLOSTRIDIUM DIFFICILE INFECTION 37 0.0017
368 HERPES SIMPLEX 11 0.0017
369 PULSELESS ELECTRICAL ACTIVITY 7 0.0017
370 HEARING IMPAIRED 10 0.0017
371 POST PROCEDURAL COMPLICATION 32 0.0017
372 SEPSIS 185 0.0017
373 NEPHROLITHIASIS 76 0.0017
374 PULMONARY THROMBOSIS 18 0.0016
375 ASPIRATION 18 0.0016
376 RESPIRATORY TRACT CONGESTION 26 0.0016
377 COUGH 458 0.0016
378 PETECHIAE 17 0.0016
379 DYSPHONIA 95 0.0016
380 HAEMATOCRIT DECREASED 32 0.0016
381 BLOOD ALKALINE PHOSPHATASE INCREASED 40 0.0016
382 MYASTHENIA GRAVIS 13 0.0016
383 EPSTEIN-BARR VIRUS INFECTION 10 0.0016
384 ABNORMAL FAECES 13 0.0016
385 PHYSICAL DISABILITY 7 0.0016
386 DERMATITIS CONTACT 18 0.0016
387 RENAL FAILURE CHRONIC 12 0.0016
388 ANHEDONIA 41 0.0016
389 PANCREATITIS ACUTE 35 0.0016
390 MULTIPLE ALLERGIES 12 0.0015
391 FEBRILE NEUTROPENIA 101 0.0015
392 POLYARTHRITIS 8 0.0015
393 INFLAMMATION 78 0.0015
394 UNRESPONSIVE TO STIMULI 39 0.0015
395 ARTHRITIS INFECTIVE 7 0.0015
396 FOOD POISONING 8 0.0015
397 URINE OUTPUT DECREASED 13 0.0015
398 CONDITION AGGRAVATED 451 0.0015
399 SINUS CONGESTION 20 0.0015
400 CARDIAC TAMPONADE 7 0.0015
401 DECUBITUS ULCER 12 0.0015
402 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
403 TACHYPNOEA 20 0.0015
404 CONCOMITANT DISEASE AGGRAVATED 9 0.0015
405 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 76 0.0015
406 INFLUENZA 162 0.0015
407 SPLENOMEGALY 17 0.0014
408 INFUSION SITE EXTRAVASATION 9 0.0014
409 BLOOD BILIRUBIN INCREASED 39 0.0014
410 ABDOMINAL TENDERNESS 7 0.0014
411 SINUSITIS 144 0.0014
412 BRONCHITIS 104 0.0014
413 TREATMENT FAILURE 116 0.0014
414 PLEURAL EFFUSION 85 0.0014
415 ABNORMAL SENSATION IN EYE 6 0.0014
416 CARDIOGENIC SHOCK 20 0.0014
417 ECONOMIC PROBLEM 21 0.0014
418 CHEST DISCOMFORT 141 0.0014
419 RHINITIS 11 0.0014
420 FAILURE TO THRIVE 7 0.0013
421 MENINGITIS 9 0.0013
422 BRAIN OEDEMA 17 0.0013
423 PANCYTOPENIA 75 0.0013
424 PERICARDIAL EFFUSION 31 0.0013
425 SERUM FERRITIN INCREASED 7 0.0013
426 ABSCESS 21 0.0013
427 EYE MOVEMENT DISORDER 9 0.0013
428 INFUSION SITE ERYTHEMA 11 0.0013
429 ILL-DEFINED DISORDER 79 0.0013
430 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
431 ASCITES 38 0.0013
432 ELECTROLYTE IMBALANCE 15 0.0013
433 ILEUS 16 0.0013
434 LOWER RESPIRATORY TRACT INFECTION 58 0.0013
435 AUTISM SPECTRUM DISORDER 7 0.0013
436 SINUS TACHYCARDIA 18 0.0013
437 QUALITY OF LIFE DECREASED 17 0.0013
438 GAMMA-GLUTAMYLTRANSFERASE INCREASED 28 0.0013
439 EYE INFLAMMATION 12 0.0013
440 SPINAL OSTEOARTHRITIS 11 0.0013
441 ENTERITIS 8 0.0012
442 CHOLESTASIS 24 0.0012
443 PYREXIA 428 0.0012
444 CHOLECYSTITIS ACUTE 7 0.0012
445 LIQUID PRODUCT PHYSICAL ISSUE 9 0.0012
446 MOUTH HAEMORRHAGE 9 0.0012
447 ASPARTATE AMINOTRANSFERASE INCREASED 65 0.0012
448 VENTRICULAR SEPTAL DEFECT 7 0.0012
449 CONTRAINDICATED PRODUCT ADMINISTERED 37 0.0012
450 ALANINE AMINOTRANSFERASE INCREASED 75 0.0012
451 DYSPNOEA 688 0.0012
452 OSTEOMYELITIS 22 0.0012
453 GENERALISED OEDEMA 15 0.0012
454 PHARYNGITIS 15 0.0012
455 DECREASED ACTIVITY 13 0.0012
456 PERIPHERAL SENSORY NEUROPATHY 7 0.0012
457 POST-TRAUMATIC STRESS DISORDER 8 0.0012
458 EYE DISORDER 39 0.0012
459 GLUCOSE TOLERANCE IMPAIRED 7 0.0012
460 PRODUCT USE IN UNAPPROVED INDICATION 293 0.0012
461 THROMBOCYTOPENIA 132 0.0012
462 ATAXIA 14 0.0012
463 GENERAL PHYSICAL CONDITION ABNORMAL 8 0.0012
464 DRUG TOXICITY 16 0.0012
465 SHOCK 27 0.0012
466 ODYNOPHAGIA 7 0.0012
467 EAR INFECTION 31 0.0012
468 BRONCHOPULMONARY ASPERGILLOSIS 9 0.0012
469 BONE DISORDER 21 0.0012
470 MENTAL STATUS CHANGES 32 0.0012
471 LARGE INTESTINE PERFORATION 8 0.0012
472 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 63 0.0011
473 WEIGHT FLUCTUATION 12 0.0011
474 DRUG INTOLERANCE 110 0.0011
475 TUMOUR LYSIS SYNDROME 10 0.0011
476 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
477 PAPULE 8 0.0011
478 THERAPY NON-RESPONDER 51 0.0011
479 SCOLIOSIS 7 0.0011
480 MYOSITIS 10 0.0011
481 LIGAMENT SPRAIN 11 0.0011
482 CELLULITIS 56 0.0011
483 FUNGAL INFECTION 37 0.0011
484 HYPOCALCAEMIA 21 0.0011
485 BLOOD POTASSIUM INCREASED 18 0.0011
486 GASTROENTERITIS VIRAL 20 0.0011
487 PNEUMONITIS 30 0.0011
488 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
489 CARDIOMYOPATHY 16 0.0011
490 HYPERSOMNIA 31 0.0011
491 CYANOSIS 17 0.0011
492 PRODUCT DISTRIBUTION ISSUE 10 0.0011
493 THERAPY INTERRUPTED 77 0.0011
494 HEPATIC STEATOSIS 20 0.0011
495 LIVER FUNCTION TEST INCREASED 23 0.0011
496 PRESYNCOPE 26 0.0011
497 BLOOD CALCIUM DECREASED 12 0.0011
498 GALLBLADDER DISORDER 19 0.0011
499 DYSPNOEA EXERTIONAL 40 0.0011
500 HYPOKALAEMIA 49 0.0011
501 RESPIRATORY DEPRESSION 13 0.0011
502 MITRAL VALVE INCOMPETENCE 12 0.0011
503 VENTRICULAR EXTRASYSTOLES 11 0.0011
504 TENDERNESS 11 0.0011
505 HYPERKALAEMIA 37 0.0011
506 HYPERCALCAEMIA 13 0.0011
507 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
508 IMPAIRED QUALITY OF LIFE 15 0.0010
509 BLOOD MAGNESIUM DECREASED 9 0.0010
510 SCRATCH 11 0.0010
511 PSYCHOLOGICAL TRAUMA 9 0.0010
512 PULMONARY FIBROSIS 20 0.0010
513 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
514 PNEUMONIA ASPIRATION 26 0.0010
515 DRUG INTERACTION 164 0.0010
516 NEUROPATHY PERIPHERAL 98 0.0010
517 RASH ERYTHEMATOUS 49 0.0010
518 RIB FRACTURE 21 0.0010
519 RENAL CYST 8 0.0010
520 PULMONARY MASS 15 0.0010
521 OESOPHAGITIS 11 0.0010
522 GINGIVAL PAIN 8 0.0010
523 GASTROINTESTINAL INFECTION 9 0.0010
524 FOOT FRACTURE 19 0.0010
525 TOOTH FRACTURE 11 0.0010
526 OSTEOPOROSIS 41 0.0010
527 MUSCULOSKELETAL DISCOMFORT 17 0.0010
528 HEPATIC ENZYME INCREASED 67 0.0010
529 RETINAL HAEMORRHAGE 7 0.0010
530 SHOCK HAEMORRHAGIC 8 0.0010
531 BLINDNESS 40 0.0010
532 DELIRIUM 34 0.0010
533 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 7 0.0010
534 FEELING COLD 27 0.0010
535 LETHARGY 55 0.0010
536 SKIN LESION 26 0.0009
537 MUSCLE ATROPHY 12 0.0009
538 NEUTROPENIA 128 0.0009
539 CATARACT 56 0.0009
540 HYPOTENSION 188 0.0009
541 SNEEZING 21 0.0009
542 VITAMIN D DECREASED 8 0.0009
543 HYPOMAGNESAEMIA 13 0.0009
544 COVID-19 PNEUMONIA 11 0.0009
545 HEART RATE IRREGULAR 21 0.0009
546 TACHYCARDIA 82 0.0009
547 HAEMORRHOIDS 18 0.0009
548 MYOCLONUS 11 0.0009
549 NASAL CONGESTION 54 0.0009
550 ELECTROCARDIOGRAM QT PROLONGED 33 0.0009
551 BODY TEMPERATURE DECREASED 9 0.0009
552 DEVICE RELATED INFECTION 14 0.0009
553 FOOD ALLERGY 7 0.0009
554 METABOLIC ACIDOSIS 29 0.0009
555 BLOOD PRESSURE ABNORMAL 18 0.0009
556 HYPERSENSITIVITY 168 0.0009
557 DENTAL CARIES 10 0.0009
558 INTESTINAL OBSTRUCTION 34 0.0009
559 BLOOD SODIUM DECREASED 17 0.0009
560 SALIVARY HYPERSECRETION 9 0.0009
561 LEUKOPENIA 45 0.0009
562 WEIGHT DECREASED 251 0.0009
563 COMPLICATION ASSOCIATED WITH DEVICE 13 0.0009
564 PULMONARY OEDEMA 40 0.0009
565 OFF LABEL USE 778 0.0009
566 EYELID PTOSIS 9 0.0009
567 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63 0.0009
568 AGEUSIA 22 0.0009
569 TRICUSPID VALVE INCOMPETENCE 7 0.0009
570 HAEMATURIA 30 0.0009
571 LOCALISED INFECTION 21 0.0009
572 TOXICITY TO VARIOUS AGENTS 146 0.0009
573 SLEEP DISORDER 61 0.0009
574 CHEST PAIN 160 0.0009
575 HYPOPHAGIA 22 0.0009
576 MASS 12 0.0009
577 GASTROOESOPHAGEAL REFLUX DISEASE 69 0.0009
578 TRANSAMINASES INCREASED 19 0.0009
579 HEART RATE DECREASED 30 0.0009
580 INFUSION SITE PAIN 11 0.0009
581 SURGERY 50 0.0009
582 HIATUS HERNIA 11 0.0008
583 PAIN IN JAW 24 0.0008
584 VISION BLURRED 116 0.0008
585 EMBOLISM 7 0.0008
586 INTENTIONAL DOSE OMISSION 24 0.0008
587 DRY EYE 42 0.0008
588 EOSINOPHIL COUNT INCREASED 7 0.0008
589 SEIZURE 97 0.0008
590 TENDONITIS 13 0.0008
591 ANAPHYLACTIC REACTION 46 0.0008
592 OROPHARYNGEAL PAIN 77 0.0008
593 ANOSMIA 12 0.0008
594 FLUID OVERLOAD 12 0.0008
595 NECK PAIN 46 0.0008
596 KIDNEY INFECTION 16 0.0008
597 CARDIAC OPERATION 7 0.0008
598 PRODUCT DOSE OMISSION 53 0.0008
599 JOINT SWELLING 98 0.0008
600 MUSCLE STRAIN 7 0.0008
601 NIGHT SWEATS 26 0.0008
602 INTERNATIONAL NORMALISED RATIO INCREASED 23 0.0008
603 RHINORRHOEA 52 0.0008
604 GASTROINTESTINAL DISORDER 72 0.0008
605 BLOOD POTASSIUM DECREASED 24 0.0008
606 PRODUCT USE ISSUE 150 0.0008
607 PREMATURE BABY 24 0.0008
608 STATUS EPILEPTICUS 9 0.0008
609 IMMUNOSUPPRESSION 7 0.0008
610 EMPHYSEMA 8 0.0008
611 ORAL DISCOMFORT 11 0.0008
612 RECTAL HAEMORRHAGE 34 0.0008
613 LYMPHADENOPATHY 28 0.0008
614 ATRIAL FIBRILLATION 77 0.0008
615 GASTRIC ULCER 15 0.0008
616 CARDIAC ARREST 65 0.0008
617 VENTRICULAR TACHYCARDIA 13 0.0008
618 COVID-19 138 0.0008
619 INJURY 55 0.0008
620 NEUTROPHIL COUNT INCREASED 8 0.0008
621 THERAPY CESSATION 40 0.0008
622 GENERAL PHYSICAL HEALTH DETERIORATION 90 0.0008
623 LYMPHOPENIA 11 0.0008
624 HEPATOCELLULAR INJURY 11 0.0008
625 OROPHARYNGEAL DISCOMFORT 7 0.0008
626 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
627 FACE OEDEMA 13 0.0008
628 MENTAL DISORDER 33 0.0008
629 ILLNESS 78 0.0008
630 LIVER FUNCTION TEST ABNORMAL 22 0.0008
631 HAEMOGLOBIN DECREASED 77 0.0007
632 TREATMENT NONCOMPLIANCE 41 0.0007
633 BODY HEIGHT DECREASED 8 0.0007
634 HEART RATE INCREASED 74 0.0007
635 MUSCULOSKELETAL PAIN 39 0.0007
636 SQUAMOUS CELL CARCINOMA 7 0.0007
637 FEAR 20 0.0007
638 PRODUCT ADMINISTRATION ERROR 15 0.0007
639 BURSITIS 9 0.0007
640 ADRENAL INSUFFICIENCY 9 0.0007
641 NEURALGIA 18 0.0007
642 BONE MARROW FAILURE 15 0.0007
643 IMMUNODEFICIENCY 11 0.0007
644 LIMB INJURY 20 0.0007
645 EPISTAXIS 55 0.0007
646 CHILLS 86 0.0007
647 DRUG ERUPTION 13 0.0007
648 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
649 HYPONATRAEMIA 41 0.0007
650 VENTRICULAR FIBRILLATION 8 0.0007
651 VITAMIN D DEFICIENCY 7 0.0007
652 UNEVALUABLE EVENT 54 0.0007
653 HYPERGLYCAEMIA 26 0.0007
654 MOUTH ULCERATION 15 0.0007
655 THERAPY CHANGE 7 0.0007
656 FISTULA 8 0.0007
657 IMPAIRED HEALING 23 0.0007
658 NASOPHARYNGITIS 129 0.0007
659 CEREBRAL INFARCTION 17 0.0007
660 GASTRIC HAEMORRHAGE 8 0.0007
661 PULMONARY ARTERIAL HYPERTENSION 10 0.0007
662 DRY THROAT 7 0.0007
663 DEVICE USE ISSUE 12 0.0007
664 COLITIS 26 0.0007
665 MUSCULOSKELETAL STIFFNESS 60 0.0007
666 BACK PAIN 159 0.0007
667 MATERNAL EXPOSURE DURING PREGNANCY 61 0.0007
668 MEDICATION ERROR 38 0.0007
669 EYE HAEMORRHAGE 9 0.0007
670 CHOLECYSTITIS 8 0.0007
671 HAEMATEMESIS 17 0.0007
672 METASTASES TO BONE 11 0.0007
673 HYPERLIPIDAEMIA 8 0.0007
674 POLYNEUROPATHY 8 0.0007
675 THROAT TIGHTNESS 18 0.0007
676 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
677 HALLUCINATION, VISUAL 14 0.0007
678 PULMONARY EMBOLISM 63 0.0007
679 PANCREATITIS 35 0.0007
680 CYTOMEGALOVIRUS INFECTION 11 0.0007
681 VISUAL IMPAIRMENT 82 0.0007
682 DEHYDRATION 88 0.0007
683 BALANCE DISORDER 57 0.0007
684 GINGIVAL BLEEDING 9 0.0007
685 CYTOPENIA 8 0.0007
686 URINARY TRACT INFECTION 111 0.0007
687 PHARYNGITIS STREPTOCOCCAL 7 0.0006
688 OSTEONECROSIS OF JAW 16 0.0006
689 CIRCULATORY COLLAPSE 11 0.0006
690 BACK INJURY 7 0.0006
691 HEPATIC FUNCTION ABNORMAL 24 0.0006
692 SCAR 11 0.0006
693 CHOLELITHIASIS 21 0.0006
694 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
695 WOUND INFECTION 7 0.0006
696 BRAIN FOG 10 0.0006
697 PRODUCT DOSE OMISSION ISSUE 187 0.0006
698 PRODUCT USE COMPLAINT 10 0.0006
699 HEPATOTOXICITY 14 0.0006
700 ACCIDENTAL OVERDOSE 23 0.0006
701 PREMATURE DELIVERY 10 0.0006
702 OEDEMA 34 0.0006
703 PALLOR 17 0.0006
704 PARAESTHESIA ORAL 9 0.0006
705 RASH GENERALISED 16 0.0006
706 LACTIC ACIDOSIS 20 0.0006
707 GASTROENTERITIS 9 0.0006
708 DIPLOPIA 16 0.0006
709 MALAISE 270 0.0006
710 SWELLING FACE 40 0.0006
711 OSTEOARTHRITIS 26 0.0006
712 DECREASED APPETITE 141 0.0006
713 RASH 263 0.0006
714 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 11 0.0006
715 VERTIGO 36 0.0006
716 DISEASE RECURRENCE 28 0.0006
717 ANGIOEDEMA 26 0.0006
718 VOMITING 276 0.0006
719 CONSTIPATION 128 0.0006
720 LIVER DISORDER 26 0.0006
721 ACCIDENT 7 0.0006
722 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 10 0.0006
723 CONTUSION 56 0.0006
724 RESPIRATORY ARREST 16 0.0006
725 RENAL DISORDER 27 0.0006
726 CONVULSION 33 0.0006
727 NOCTURIA 7 0.0006
728 SLEEP APNOEA SYNDROME 11 0.0006
729 CHROMATURIA 13 0.0006
730 CARDIO-RESPIRATORY ARREST 24 0.0006
731 SEROTONIN SYNDROME 11 0.0006
732 DIARRHOEA 369 0.0006
733 LIP SWELLING 19 0.0006
734 BLISTER 32 0.0006
735 TENDON RUPTURE 7 0.0006
736 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
737 OBESITY 9 0.0006
738 RETCHING 12 0.0006
739 DEATH 482 0.0006
740 ARTHRITIS 44 0.0006
741 INFLUENZA LIKE ILLNESS 46 0.0006
742 THROAT IRRITATION 25 0.0006
743 HEADACHE 349 0.0006
744 ABDOMINAL DISTENSION 58 0.0006
745 ABDOMINAL PAIN 129 0.0006
746 PRODUCT DISPENSING ERROR 12 0.0006
747 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
748 CYTOKINE RELEASE SYNDROME 11 0.0005
749 EXPOSURE DURING PREGNANCY 34 0.0005
750 BRADYCARDIA 29 0.0005
751 RHEUMATOID ARTHRITIS 62 0.0005
752 ROTATOR CUFF SYNDROME 7 0.0005
753 PHOTOSENSITIVITY REACTION 9 0.0005
754 RASH MACULAR 19 0.0005
755 ANXIETY 154 0.0005
756 HERPES ZOSTER 31 0.0005
757 DRUG INEFFECTIVE 710 0.0005
758 DEEP VEIN THROMBOSIS 35 0.0005
759 AGRANULOCYTOSIS 10 0.0005
760 WOUND 15 0.0005
761 SPEECH DISORDER 28 0.0005
762 OEDEMA PERIPHERAL 65 0.0005
763 BEDRIDDEN 7 0.0005
764 DISEASE PROGRESSION 63 0.0005
765 URTICARIA 89 0.0005
766 HOT FLUSH 40 0.0005
767 HEPATIC FAILURE 16 0.0005
768 TOOTH LOSS 11 0.0005
769 DYSPEPSIA 52 0.0005
770 STOMATITIS 32 0.0005
771 RHABDOMYOLYSIS 22 0.0005
772 BLOOD URINE PRESENT 10 0.0005
773 MIGRAINE 50 0.0005
774 ARTHROPATHY 29 0.0005
775 LOWER LIMB FRACTURE 10 0.0005
776 JAUNDICE 14 0.0005
777 ANAEMIA 99 0.0005
778 LYMPHOMA 8 0.0005
779 FATIGUE 403 0.0005
780 MUSCULOSKELETAL CHEST PAIN 8 0.0005
781 EATING DISORDER 11 0.0005
782 FAECES DISCOLOURED 11 0.0005
783 EMOTIONAL DISTRESS 61 0.0005
784 SKIN ULCER 13 0.0005
785 CYSTITIS 16 0.0005
786 HIP FRACTURE 16 0.0005
787 APHASIA 15 0.0005
788 C-REACTIVE PROTEIN INCREASED 18 0.0005
789 TOOTH DISORDER 11 0.0005
790 DEPRESSION 112 0.0005
791 ORAL PAIN 11 0.0005
792 MULTIPLE FRACTURES 8 0.0005
793 PRODUCT PREPARATION ERROR 10 0.0005
794 ABDOMINAL PAIN UPPER 100 0.0005
795 DIABETES MELLITUS 37 0.0005
796 BLOOD PRESSURE INCREASED 74 0.0005
797 INFUSION RELATED REACTION 32 0.0005
798 CONFUSIONAL STATE 78 0.0005
799 BLOOD PRESSURE DECREASED 32 0.0005
800 FREQUENT BOWEL MOVEMENTS 13 0.0005
801 PERIPHERAL SWELLING 74 0.0005
802 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
803 SWOLLEN TONGUE 15 0.0005
804 HEPATIC CIRRHOSIS 9 0.0005
805 BONE DENSITY DECREASED 15 0.0005
806 SKIN DISCOLOURATION 22 0.0005
807 DERMATITIS 10 0.0005
808 MUSCLE TWITCHING 11 0.0005
809 ERYTHEMA 98 0.0005
810 ASTHENIA 179 0.0005
811 PSYCHOTIC DISORDER 14 0.0005
812 INCREASED APPETITE 9 0.0005
813 NAUSEA 370 0.0005
814 HYPERTENSION 99 0.0005
815 GLAUCOMA 9 0.0005
816 EAR PAIN 9 0.0005
817 SKIN EXFOLIATION 39 0.0005
818 RASH PRURITIC 25 0.0005
819 RED BLOOD CELL COUNT DECREASED 13 0.0005
820 DEPRESSED MOOD 24 0.0005
821 MENTAL IMPAIRMENT 11 0.0005
822 DYSPHAGIA 43 0.0005
823 FLUID RETENTION 23 0.0005
824 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
825 LIVER INJURY 11 0.0004
826 DRUG-INDUCED LIVER INJURY 14 0.0004
827 PAIN 274 0.0004
828 GOUT 8 0.0004
829 THERAPEUTIC RESPONSE DECREASED 27 0.0004
830 ARRHYTHMIA 21 0.0004
831 PLATELET COUNT DECREASED 47 0.0004
832 HAEMORRHAGE 46 0.0004
833 ULCER 7 0.0004
834 ARTHRALGIA 180 0.0004
835 DISORIENTATION 17 0.0004
836 WEIGHT INCREASED 96 0.0004
837 MIDDLE INSOMNIA 8 0.0004
838 OSTEONECROSIS 14 0.0004
839 DIZZINESS 212 0.0004
840 DYSARTHRIA 16 0.0004
841 CARDIAC FAILURE CONGESTIVE 34 0.0004
842 THROMBOSIS 34 0.0004
843 AGITATION 31 0.0004
844 EMOTIONAL DISORDER 13 0.0004
845 FEELING JITTERY 8 0.0004
846 DRY SKIN 56 0.0004
847 NEUTROPHIL COUNT DECREASED 17 0.0004
848 SWELLING 39 0.0004
849 BLOOD PRESSURE FLUCTUATION 10 0.0004
850 MYELOSUPPRESSION 15 0.0004
851 INCORRECT PRODUCT ADMINISTRATION DURATION 9 0.0004
852 PANIC ATTACK 15 0.0004
853 RESTLESSNESS 15 0.0004
854 DISCOMFORT 25 0.0004
855 WHITE BLOOD CELL COUNT DECREASED 44 0.0004
856 NIGHTMARE 14 0.0004
857 RASH PAPULAR 9 0.0004
858 COMA 19 0.0004
859 CARDIAC FAILURE 32 0.0004
860 LYMPHOCYTE COUNT DECREASED 7 0.0004
861 PRODUCT AVAILABILITY ISSUE 9 0.0004
862 BODY TEMPERATURE INCREASED 8 0.0004
863 PAIN IN EXTREMITY 115 0.0004
864 FALL 129 0.0004
865 FEMUR FRACTURE 12 0.0004
866 TOOTHACHE 7 0.0004
867 ADVERSE DRUG REACTION 34 0.0004
868 PRODUCT STORAGE ERROR 33 0.0004
869 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
870 MUSCULAR WEAKNESS 42 0.0004
871 PRODUCT PRESCRIBING ISSUE 8 0.0004
872 PRURITUS 141 0.0004
873 GAIT DISTURBANCE 70 0.0004
874 MELAENA 8 0.0004
875 FEELING ABNORMAL 86 0.0004
876 SKIN FISSURES 7 0.0004
877 GASTRIC CANCER 9 0.0004
878 DISABILITY 7 0.0004
879 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
880 ABNORMAL BEHAVIOUR 14 0.0004
881 FLATULENCE 20 0.0004
882 HEPATITIS 9 0.0004
883 ABORTION SPONTANEOUS 14 0.0003
884 HEAD INJURY 11 0.0003
885 FULL BLOOD COUNT DECREASED 7 0.0003
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 62 0.0003
887 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
888 JOINT STIFFNESS 9 0.0003
889 PERITONITIS 7 0.0003
890 ALOPECIA 66 0.0003
891 CEREBRAL HAEMORRHAGE 12 0.0003
892 TREMOR 55 0.0003
893 INTERSTITIAL LUNG DISEASE 16 0.0003
894 CRYING 12 0.0003
895 HYPOGLYCAEMIA 16 0.0003
896 SKIN DISORDER 11 0.0003
897 IMPAIRED WORK ABILITY 7 0.0003
898 IRRITABLE BOWEL SYNDROME 7 0.0003
899 POOR QUALITY SLEEP 7 0.0003
900 ECZEMA 17 0.0003
901 DIVERTICULITIS 9 0.0003
902 CEREBROVASCULAR ACCIDENT 55 0.0003
903 MUSCLE SPASMS 59 0.0003
904 NO ADVERSE EVENT 58 0.0003
905 INSOMNIA 85 0.0003
906 HALLUCINATION 24 0.0003
907 IRRITABILITY 19 0.0003
908 HYPOTHYROIDISM 10 0.0003
909 GLOSSODYNIA 7 0.0003
910 POLLAKIURIA 13 0.0003
911 DYSGEUSIA 23 0.0003
912 NEEDLE ISSUE 9 0.0003
913 HAEMATOCHEZIA 17 0.0003
914 FLUSHING 31 0.0003
915 URINARY INCONTINENCE 9 0.0003
916 HYPOAESTHESIA 45 0.0003
917 SYNCOPE 30 0.0003
918 DYSURIA 11 0.0003
919 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
920 FOETAL EXPOSURE DURING PREGNANCY 24 0.0003
921 PRODUCT PRESCRIBING ERROR 7 0.0003
922 SOMNOLENCE 59 0.0003
923 ABDOMINAL DISCOMFORT 49 0.0003
924 AMNESIA 19 0.0003
925 GASTRIC DISORDER 10 0.0003
926 LIMB DISCOMFORT 9 0.0003
927 INTENTIONAL PRODUCT MISUSE 25 0.0003
928 DRY MOUTH 23 0.0003
929 HYPERHIDROSIS 36 0.0003
930 DYSSTASIA 8 0.0003
931 ACUTE MYOCARDIAL INFARCTION 8 0.0003
932 BLOOD GLUCOSE DECREASED 13 0.0003
933 DYSKINESIA 11 0.0003
934 GAIT INABILITY 9 0.0003
935 CARDIAC DISORDER 25 0.0003
936 PARAESTHESIA 42 0.0003
937 DISTURBANCE IN ATTENTION 14 0.0003
938 MEMORY IMPAIRMENT 35 0.0003
939 MOOD SWINGS 8 0.0003
940 MOVEMENT DISORDER 8 0.0002
941 INJECTION SITE SWELLING 19 0.0002
942 MYALGIA 42 0.0002
943 EXTRA DOSE ADMINISTERED 10 0.0002
944 UNDERDOSE 18 0.0002
945 DERMATITIS ATOPIC 13 0.0002
946 ANGINA PECTORIS 7 0.0002
947 LOSS OF CONSCIOUSNESS 31 0.0002
948 URINARY RETENTION 8 0.0002
949 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
950 LABORATORY TEST ABNORMAL 7 0.0002
951 MOBILITY DECREASED 17 0.0002
952 CORONARY ARTERY DISEASE 7 0.0002
953 PLASMA CELL MYELOMA 9 0.0002
954 DEVICE DISLOCATION 10 0.0002
955 NERVOUS SYSTEM DISORDER 7 0.0002
956 BURNING SENSATION 15 0.0002
957 PALPITATIONS 25 0.0002
958 TYPE 2 DIABETES MELLITUS 7 0.0002
959 DRUG DOSE OMISSION 34 0.0002
960 BONE PAIN 12 0.0002
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
962 INCORRECT DOSE ADMINISTERED 46 0.0002
963 AGGRESSION 10 0.0002
964 ACNE 15 0.0002
965 FEELING HOT 12 0.0002
966 COGNITIVE DISORDER 9 0.0002
967 ROAD TRAFFIC ACCIDENT 8 0.0002
968 BLOOD GLUCOSE INCREASED 36 0.0002
969 PRODUCT SUBSTITUTION ISSUE 11 0.0002
970 SUICIDAL IDEATION 17 0.0002
971 DEVICE LEAKAGE 8 0.0002
972 ADVERSE EVENT 17 0.0002
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 13 0.0002
974 NEOPLASM MALIGNANT 12 0.0002
975 DEVICE ISSUE 16 0.0002
976 PROSTATE CANCER 14 0.0002
977 BLOOD CHOLESTEROL INCREASED 8 0.0002
978 OVERDOSE 37 0.0002
979 INJECTION SITE ERYTHEMA 20 0.0002
980 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
981 NERVOUSNESS 8 0.0002
982 MYOCARDIAL INFARCTION 25 0.0001
983 PRODUCT QUALITY ISSUE 19 0.0001
984 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
985 INJECTION SITE PRURITUS 8 0.0001
986 DEVICE MALFUNCTION 8 0.0001
987 INJECTION SITE PAIN 33 0.0001
988 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
989 BREAST CANCER 10 0.0001
990 INJECTION SITE BRUISING 8 0.0001
991 PSORIASIS 9 0.0001
992 DRUG DEPENDENCE 11 0.0001